SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: “Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?” by Manzo et al. Joint Bone Spine 2021;88:105150 - 02/01/22
Doi : 10.1016/j.jbspin.2021.105282
Simon Cadiou a, ⁎ 
, Aleth Perdriger a, Samuel Ardois b, Jean-David Albert a, c, Olivia Berthoud a, Alain Lescoat b, d, Pascal Guggenbuhl a, c, François Robin a, c
, Aleth Perdriger a, Samuel Ardois b, Jean-David Albert a, c, Olivia Berthoud a, Alain Lescoat b, d, Pascal Guggenbuhl a, c, François Robin a, c a Department of rheumatology, Rennes university hospital, university Rennes, Rennes, France
b Department of internal medicine and clinical immunology, Rennes university hospital, university Rennes, Rennes, France
c Inserm UMR 1241, Inra, Institut NUMECAN (Nutrition Metabolisms and Cancer), university Rennes, 35000 Rennes, France
d Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) – UMR_S 1085, university Rennes, Rennes, France
⁎Corresponding author. Hôpital Sud Rennes, 16, boulevard de Bulgarie, 35000 Rennes, France.Hôpital Sud Rennes16, boulevard de BulgarieRennes35000France
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Keywords : SARS-CoV-2, COVID-19, Vaccine, Polymyalgia rheumatica, Giant cell arteritis
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2021
Pubblicato da Elsevier Masson SAS.
Vol 89 - N° 1
Articolo 105282- Gennaio 2022 Ritorno al numero
Articolo precedente
- The negative impact of depression in women with Axial Spondyloarthropathy
- Sinead Maguire, Phil Gallagher, Finbar O'Shea
- Answer to Cadiou et al. “SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger?”. Joint Bone Spine 2021;88:105282
- Ciro Manzo, Alberto Castagna, Maria Natale, Giovanni Ruotolo
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.